Home » Impax Challenges Abbott’s Patents in Connection to Tricor
Impax Challenges Abbott’s Patents in Connection to Tricor
Impax Laboratories, Inc. has initiated a challenge of the patents listed by Abbott Laboratories in connection with its TRICOR (fenofibrate) tablets, 48
mg and 145 mg.
StreetInsider
StreetInsider
Upcoming Events
-
07May
-
14May
-
23May
-
30May
-
21Oct